Stinging nettle shampoo for hair loss has become an increasingly popular choice among people in the UK seeking natural alternatives to conventional treatments. Derived from Urtica dioica, nettle is marketed as a botanical ingredient that may reduce hair shedding and support scalp health. With hair thinning affecting a significant proportion of the UK population, the appeal of an accessible, over-the-counter option is clear. However, it is essential to understand what the current evidence actually shows, how these products differ from licensed medicines, and when professional medical assessment is the more appropriate course of action.

Can Stinging Nettle Shampoo Help With Hair Loss?

Stinging nettle shampoos are cosmetic products with no MHRA licence for hair loss; evidence is largely anecdotal and they are not a substitute for medical assessment of hair thinning.

Not sure if this is normal? Chat with one of our pharmacists →

Stinging nettle (Urtica dioica) has been used in traditional herbal medicine for centuries, and in recent years it has gained popularity as an ingredient in shampoos and topical hair products marketed for hair loss. The appeal is understandable — hair thinning affects a significant proportion of the UK population, and many people seek complementary or over-the-counter options before consulting a healthcare professional.

Nettle-based shampoos are widely available in health food shops and online retailers across the UK. Proponents suggest that nettle may help reduce hair shedding, support scalp health, and potentially slow the progression of androgenetic alopecia (pattern hair loss). However, it is important to distinguish between traditional use, anecdotal reports, and robust clinical evidence.

It is worth noting that stinging nettle shampoos are cosmetic products, not licensed medicines. They are not regulated as medicines by the MHRA, and no MHRA-licensed nettle product exists for the treatment of hair loss. This means that any efficacy claims made by manufacturers are not subject to the same regulatory scrutiny as licensed medicines, and consumers should approach marketing claims with appropriate caution.

Hair loss has many underlying causes, including hormonal changes, nutritional deficiencies, autoimmune conditions, thyroid disease, certain medications, and psychological stress. No single shampoo ingredient is likely to address all causes, and delaying evidence-based assessment or treatment may allow some conditions to progress.

When to seek prompt medical advice — red flags:

• Sudden, rapid, or widespread hair loss

• Patchy loss with scalp scaling, broken hairs, or pustules (which may suggest tinea capitis, particularly in children)

• Scalp pain, tenderness, persistent redness, or scarring (which may indicate a scarring alopecia requiring urgent specialist assessment)

• Loss of eyebrows, eyelashes, or body hair

• Associated systemic symptoms such as fatigue, weight change, or skin changes

For anyone experiencing noticeable, sudden, or patchy hair loss, a consultation with a GP remains the most appropriate first step. The NHS hair loss pages and British Association of Dermatologists (BAD) patient information leaflets provide reliable, up-to-date guidance on causes and treatment options.

What the Evidence Says About Nettle and Hair Growth

Current evidence for stinging nettle and hair growth is limited to in vitro and preclinical studies; no NICE or NHS guidance supports its use for hair regrowth.

The scientific evidence supporting stinging nettle as a treatment for hair loss is currently limited and largely preliminary. Most of the proposed mechanisms are based on laboratory (in vitro) or preclinical studies rather than large, well-designed randomised controlled trials (RCTs) in humans.

One of the most frequently cited mechanisms relates to 5-alpha reductase (5-AR) inhibition. Androgenetic alopecia is driven in part by dihydrotestosterone (DHT), a hormone derived from testosterone via the enzyme 5-AR. Some in vitro studies suggest that nettle root extracts may inhibit 5-AR activity, theoretically reducing DHT levels at the scalp. These findings are preclinical and have not been reliably replicated in human clinical trials. It also remains unclear whether topical application via a rinse-off shampoo delivers sufficient concentrations to the scalp to produce any meaningful biological effect — contact time is brief and scalp bioavailability of botanical extracts from rinse-off products is generally uncertain.

Nettle also contains bioactive compounds — including flavonoids, polyphenols, and lectins — that may have anti-inflammatory properties in laboratory settings. Scalp inflammation is associated with certain forms of hair loss, so reducing local inflammation could theoretically support a healthier follicular environment. Again, direct clinical evidence in humans is lacking.

It is also important to note that:

• Products vary considerably in which part of the plant is used (root versus leaf), the concentration of extract, and the overall formulation — making comparisons between studies and products difficult

• A small number of studies have examined nettle in combination with other herbal ingredients, making it impossible to isolate nettle's specific contribution

• Evidence from oral or concentrated herbal extracts cannot be directly extrapolated to rinse-off shampoo formulations

There are currently no NICE or NHS recommendations supporting stinging nettle shampoo for hair regrowth. Researchers continue to investigate plant-derived compounds in dermatology, and future well-designed human studies may provide clearer answers. Until then, nettle shampoo should be regarded as a complementary option rather than a proven treatment.

How to Use Nettle Shampoo Safely on the Scalp

Patch test before first use and follow manufacturer instructions; avoid use on broken or inflamed scalp skin, and seek medical advice if pregnant, breastfeeding, or if any adverse reaction occurs.

Experiencing these side effects? Our pharmacists can help you navigate them →

For those who choose to try stinging nettle shampoo, using it safely and with realistic expectations is important. When used as a topical rinse-off shampoo, stinging nettle is generally considered well tolerated by most people. However, as with any cosmetic or herbal product, there are safety considerations to keep in mind.

Patch testing is strongly recommended before first use, particularly for individuals with sensitive skin, eczema, psoriasis, or a history of contact dermatitis. Apply a small amount of the product to the inner forearm and wait 24–48 hours to check for any adverse reaction such as redness, itching, or swelling. If any reaction occurs, discontinue use immediately.

When using nettle shampoo:

• Follow the manufacturer's instructions regarding frequency of use and contact time

• Avoid contact with the eyes; rinse thoroughly with water if accidental contact occurs

• Do not use on broken, inflamed, or infected scalp skin without first seeking medical advice

• Be aware that some products combine nettle with other active ingredients (e.g., caffeine, saw palmetto, ketoconazole) — check the full ingredient list if you have known allergies or sensitivities

• If you are pregnant or breastfeeding, seek advice from your GP or pharmacist before using new topical products containing active botanical ingredients

Safety-netting: Stop use immediately and seek urgent medical attention if you experience symptoms that may suggest a severe allergic reaction, such as facial swelling, difficulty breathing, or widespread urticaria. For milder reactions such as scalp irritation or increased shedding, stop use and consult your GP or a pharmacist.

If you suspect that a cosmetic or herbal product has caused an adverse reaction, you can report this via the MHRA Yellow Card Scheme (available at yellowcard.mhra.gov.uk). This scheme allows patients and healthcare professionals to report suspected side effects to medicines, herbal remedies, and certain other products, and helps improve safety monitoring across the UK.

Maintain realistic expectations: hair growth cycles are slow, and any potential benefit from a topical product may take several months to become apparent — if it occurs at all. Sudden or patchy hair loss should always be assessed by a healthcare professional to rule out underlying medical conditions.

Other NHS-Recognised Options for Treating Hair Loss

Topical minoxidil and prescription finasteride are the most evidence-supported treatments for androgenetic alopecia; baricitinib has NICE approval for severe alopecia areata in adults.

Whilst stinging nettle shampoo may appeal as a natural option, it is helpful to be aware of treatments that are supported by clinical evidence and recognised within NHS and NICE guidance. The most appropriate treatment will depend on the underlying cause of hair loss, which is why accurate diagnosis is essential.

Initial GP assessment typically includes a clinical history and examination, and may involve blood tests guided by the clinical picture — for example, full blood count (FBC), serum ferritin, and thyroid-stimulating hormone (TSH) — to identify common reversible causes such as iron deficiency, thyroid dysfunction, or other systemic conditions. A medication review is also important, as a number of commonly prescribed drugs can contribute to hair loss. Referral to a dermatologist is appropriate where the diagnosis is uncertain, where scarring alopecia is suspected, or where first-line treatments have not been effective.

For androgenetic alopecia (pattern hair loss):

• Minoxidil (available over the counter as a topical solution or foam) is one of the most widely used and evidence-supported treatments for both male and female pattern hair loss. It works by prolonging the anagen (growth) phase of the hair cycle and increasing follicular size. Topical minoxidil should be used with caution in pregnancy and breastfeeding — seek advice from a healthcare professional before use in these circumstances. Refer to the product's Summary of Product Characteristics (SmPC), available via the Electronic Medicines Compendium (EMC), for full prescribing information.

• Finasteride 1 mg (prescription only, licensed for men with male pattern hair loss) is a 5-AR inhibitor that reduces DHT levels systemically. It is contraindicated in pregnancy due to teratogenic risk and is not licensed for use in women; it may occasionally be considered off-label in postmenopausal women under specialist supervision. The MHRA has issued Drug Safety Updates highlighting risks of depression, suicidal ideation, and persistent sexual dysfunction associated with finasteride — patients should be counselled about these risks before starting treatment.

• Both minoxidil and finasteride require ongoing use to maintain effect; hair loss typically resumes upon discontinuation.

For alopecia areata (an autoimmune condition causing patchy hair loss):

• The NHS may offer treatments such as corticosteroid injections or topical immunotherapy, depending on the extent and pattern of involvement.

• Baricitinib, a JAK inhibitor, has received NICE Technology Appraisal approval for the treatment of severe alopecia areata in adults. Patients should discuss eligibility and local commissioning status with their dermatologist. Other JAK inhibitors, including ritlecitinib, may also be available in some settings — your specialist can advise on current options.

For hair loss related to nutritional deficiencies (e.g., iron deficiency, low ferritin, vitamin D deficiency), addressing the underlying deficiency through diet or supplementation — guided by blood test results — is the primary approach.

If you are concerned about hair loss, your GP can arrange appropriate investigations and refer you to a dermatologist if needed. The British Association of Dermatologists (BAD) patient information leaflets and NHS hair loss pages provide reliable, up-to-date information on all recognised treatment pathways. NICE Clinical Knowledge Summaries (CKS) on androgenetic alopecia and alopecia areata offer further guidance aligned to UK primary care practice.

Frequently Asked Questions